Robert Stanley Tutag is Director at CORGENIX MEDICAL CORP/CO (CONX). They have made 5 open-market trades across 1 company since 2006, most recently 2015-03-10.
CIK 0001341182
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
5 open-market purchases totalling $104K since 2006, never a sale. Across 5 scored buys the stock is up 2.0% at ninety days, and 1.7 points ahead of the S&P over the same stretch.
5 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| CONX | 961,000 | $5.7M |
Shares reported on the most recent Form 4, priced at the 2011-10-11 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 100% | 100% |
| Avg Move | +2.3% | +2.0% | +2.0% |
| Alpha | -84.4% | +1.7% | +1.7% |
| Scored | 5 | 5 | 5 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CONX | BUY | 2011-10-10 | 2011-10-11 | $0.10 | $75K | +2.3% | +2.0% | +2.0% |
| CONX | BUY | 2010-10-06 | 2010-10-12 | $0.11 | $8K | +2.3% | +2.0% | +2.0% |
| CONX | BUY | 2010-09-27 | 2010-09-29 | $0.11 | $550 | +2.3% | +2.0% | +2.0% |
| CONX | BUY | 2008-05-29 | 2008-06-03 | $0.24 | $5K | +2.3% | +2.0% | +2.0% |
| CONX | BUY | 2006-02-22 | 2006-02-28 | $0.39 | $16K | +2.3% | +2.0% | +2.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.